NCT03230253

Brief Summary

The purposes are to: (1) examine and compare the effects of two hybrid interventions on brain plasticity, physiological biomarkers and behavioral outcomes, including cognitive and physical functions, from pre- to post-training; (2) understand the neural mechanisms of cognitive recovery following two hybrid interventions using the functional magnetic resonance imaging (fMRI); (3) examine the long-term benefits of the two hybrid therapies; (4) to identify the correlations between brain activity, biomarkers and behavioral measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 26, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

April 19, 2018

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 3, 2020

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
Last Updated

October 26, 2020

Status Verified

September 1, 2020

Enrollment Period

2.2 years

First QC Date

July 18, 2017

Last Update Submit

October 22, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • fMRI (change is being assessed)

    Resting-state functional connectivity and neural activation in the frontal, parietal and occipital lobes

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months).

Secondary Outcomes (22)

  • Serum BDNF level

    Baseline, posttest (an expected average of 3 months)

  • Antioxidative marker

    Baseline, posttest (an expected average of 3 months)]

  • Glucose indicator

    Baseline, posttest (an expected average of 3 months)

  • Plasma lipid level

    Baseline, posttest (an expected average of 3 months)

  • Montreal Cognitive Assessment (MoCA)

    Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  • +17 more secondary outcomes

Study Arms (3)

Sequential training group

EXPERIMENTAL

Exercise training for 30 minutes followed by 30 minutes of cognitive-based intervention

Behavioral: Sequential training

Dual training group

EXPERIMENTAL

Exercise training simultaneously combined cognitive-based intervention for 60 minutes

Behavioral: Dual training

Control training group

ACTIVE COMPARATOR

non-aerobic exercise (e.g., stretch, range of motion exercise...) and unstructured cognitive rehabilitation programs (e.g., reading newspapers, playing board games...) for 60 minutes

Behavioral: Control training

Interventions

The participant will cycle on a stationary bike for 30 minutes, which includes a 3-min warm-up phase followed by the aerobic training components (25 minutes), then a 2-min cool-down phase. The target heart rate during the aerobic training phase will be 40 to 70% of maximal heart rate (HRmax). After cycling, the participant will engage in a 30-minute of computer-based cognitive training program using BrainHQ (Posit Science Inc., San Francisco, CA, USA). The following are the areas of training: visuospatial processing, attention, memory, language, and logical thinking.

Sequential training group
Dual trainingBEHAVIORAL

The dual-task training group will cycling concurrently with the computer-based cognitive training. The training principle of cycling and cognitive training is similar to the SEQ group; however, the training intensity will be adjusted according to each participant's ability.

Dual training group

The control participants will receive 60 minutes of health-related rehabilitation programs which involves non-aerobic physical exercise (e.g., muscle stretching, range of motion exercises, relaxation techniques) and unstructured cognitive related rehabilitation programs (e.g., watch health-related videos or read newspapers or magazines and then answer the content-related questions raised by the therapist).

Control training group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke occurring at least 6 months prior to enrollment
  • Age range from 20 to 80 years
  • MMSE score \< 28 or MoCA\<25
  • Able to follow the study instruction
  • Adequate cardiopulmonary function to perform aerobic exercise
  • Able to walk with or without assistive devices

You may not qualify if:

  • Unstable medical history (e.g., recent myocardial infarction) that might limit participation
  • Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)
  • Current participation in another interventional trial
  • Any contraindication to MRI (metallic implants, claustrophobia, seizure, pacemakers, et al)
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Municipal Siaogang Hospital

Kaohsiung City, 812, Taiwan

Location

Related Publications (2)

  • Yeh TT, Chang KC, Wang JJ, Lin WC, Wu CY. Neuroplastic Changes Associated With Hybrid Exercise-Cognitive Training in Stroke Survivors With Mild Cognitive Decline: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2023 Sep;37(9):662-673. doi: 10.1177/15459683231200220.

  • Gibson E, Koh CL, Eames S, Bennett S, Scott AM, Hoffmann TC. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3.

Study Officials

  • Ching-yi Wu, ScD

    Chang Gung University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2017

First Posted

July 26, 2017

Study Start

April 19, 2018

Primary Completion

July 3, 2020

Study Completion

July 31, 2020

Last Updated

October 26, 2020

Record last verified: 2020-09

Locations